Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Giunti Psychometrics Holding SpAFRA:0ZD 16 Return-on-Tangible-Equity is Negative Tangible Equity% as of Dec. 2025. GuruFocus rates FRA:0ZD with a GF Score™ of 16/100. Among 757 Medical Devices & Instruments companies, Giunti Psychometrics Holding SpA ranks better than 99.87% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Giunti Psychometrics Holding SpA's annualized net income for the quarter that ended in Dec. 2025 was €1.60 Mil. Giunti Psychometrics Holding SpA's average shareholder tangible equity for the quarter that ended in Dec. 2025 was €-3.22 Mil. Therefore, Giunti Psychometrics Holding SpA's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was Negative Tangible Equity%.
The historical rank and industry rank for Giunti Psychometrics Holding SpA's Return-on-Tangible-Equity or its related term are showing as below:
FRA:0ZD'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0
Current: Negative Tangible Equity
FRA:0ZD's Return-on-Tangible-Equity is ranked better than 99.87% of 757
companies
in the Medical Devices & Instruments industry
Industry Median: 4.82
vs FRA:0ZD: Negative Tangible Equity
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Giunti Psychometrics Holding SpA Return-on-Tangible-Equity Related Terms
Giunti Psychometrics Holding SpA Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:0ZD vs ABT, SYK, MDT: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, Giunti Psychometrics Holding SpA's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Giunti Psychometrics Holding SpA Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Giunti Psychometrics Holding SpA's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Giunti Psychometrics Holding SpA's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is one times the annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of Negative Tangible Equity% mean?
Giunti Psychometrics Holding SpA (FRA:0ZD) has a Return-on-Tangible-Equity of Negative Tangible Equity% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Giunti Psychometrics Holding SpA and its competitors. According to the industry distribution chart, Giunti Psychometrics Holding SpA ranks #1 out of 757 companies in the Medical Devices & Instruments industry, placing it in the top 0.099999999999994%.
Is Giunti Psychometrics Holding SpA's Return-on-Tangible-Equity too high?
Giunti Psychometrics Holding SpA's current Return-on-Tangible-Equity is Negative Tangible Equity%. Based on the distribution chart, Giunti Psychometrics Holding SpA ranks #1 out of 757 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Giunti Psychometrics Holding SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Giunti Psychometrics Holding SpA's Return-on-Tangible-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Giunti Psychometrics Holding SpA ranks #1 out of 757 companies for Return-on-Tangible-Equity. This places Giunti Psychometrics Holding SpA in the top 0% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 4.82. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.82, based on 757 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Giunti Psychometrics Holding SpA and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Giunti Psychometrics Holding SpA's current Return-on-Tangible-Equity is Negative Tangible Equity%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Giunti Psychometrics Holding SpA stock overvalued right now?
Giunti Psychometrics Holding SpA (FRA:0ZD) has a current Return-on-Tangible-Equity of Negative Tangible Equity%. The current Return-on-Tangible-Equity is Negative Tangible Equity%. Giunti Psychometrics Holding SpA's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Giunti Psychometrics Holding SpA (FRA:0ZD), the current Return-on-Tangible-Equity is Negative Tangible Equity% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Giunti Psychometrics Holding SpA operates internationally in the field of psychological assessment. The company designs, develops, and distributes tools and methodologies for psychologicaland psycho-aptitude assessment, used in various fields, including clinical practice (clinical and health psychology, child psychiatry and neuropsychiatry, neuropsychology and speech therapy), human resources management (work and organizational psychology), and education and guidance (level assessment tests, tools for diagnosing learning difficulties, and tools for school, university, and career guidance). The majority of revenue is derived from sales in the mental health and clinical area.
16GF Score
Get the complete analysis for FRA:0ZD
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:0ZD has been successfully added to your 
